Catheter Precision (Catheter Precision) COGS-to-Revenue : 0.06 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Catheter Precision COGS-to-Revenue?

Catheter Precision's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.01 Mil. Its Revenue for the three months ended in Mar. 2024 was $0.08 Mil.

Catheter Precision's COGS to Revenue for the three months ended in Mar. 2024 was 0.06.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Catheter Precision's Gross Margin % for the three months ended in Mar. 2024 was 93.90%.

Catheter Precision COGS-to-Revenue Historical Data

The historical data trend for Catheter Precision's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catheter Precision COGS-to-Revenue Chart

Catheter Precision Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

1.23

8.39

70.91

11.50

0.07

Catheter Precision Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.12	0.07	0.05	0.05	0.06

Catheter Precision COGS-to-Revenue Calculation

Catheter Precision's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.03	/	0.442
	=	0.07

Catheter Precision's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.005	/	0.082
	=	0.06

Catheter Precision (AMEX:VTAK) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Catheter Precision's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.005 / 0.082
	=	93.90 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Catheter Precision COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Catheter Precision's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Catheter Precision (Catheter Precision) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Catheter Precision Inc (AMEX:VTAK) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

4RM:Germany

Address

1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708

Website

https://www.ramed.com

Catheter Precision Inc Formerly Ra Medical Systems Inc is a commercial-stage medical device company whose business comprises of the design, manufacture and sale of new medical technologies in the field of cardiac electrophysiology, or EP. Its product, View into Ventricular Onset System or VIVO System which is a non invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. . It operates business as one segment which includes all activities related to the marketing, sales and development of medical technologies in the field of cardiac EP.

Executives

David A Jenkins	director, officer: Executive Chairman of Board	P.O. BOX 682838, PARK CITY UT 84068
Steven K Passey	officer: Chief Financial Officer	3216 SOUTH HIGHLAND DRIVE, SUITE 200, SALT LAKE CITY UT 84117
James Joseph Caruso	director	28 FIRST AVE, SEASIDE PARK NJ 08752
Brian Conn	officer: Chief Financial Officer	MICROISLET, INC., 6370 NANCY RIDGE DRIVE, SUITE 112, SAN DIEGO CA 92121
Andrew C. Jackson	officer: CFO & Secretary	11988 EL CAMINO REAL STE. 650, SAN DIEGO CA 92130
Jonathan Will Mcguire	director, officer: Chief Executive Officer	96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Susanne Meline	director	P.O. BOX 515381, #86506, LOS ANGELES CA 90051
Martin J Colombatto	director
Richard Jr Mejia	director	2200 FARADAY AVENUE, SUITE 100, CARLSBAD CA 92008
William R Enquist	director	11810 WILLS ROAD, ALPHARETTA GA 30009
Joan Stafslien	director	CAREFUSION CORPORATION, 3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Daniel Horwood	officer: General Counsel	C/O RA MEDICAL SYTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011
Jeffrey J Kraws	officer: Co-President	3985 RESEARCH PARK DRIVE, ANN ARBOR MI 48108
Dean Irwin	director, 10 percent owner, officer: See Remarks	C/O RA MEDICAL SYSTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011
Martin Burstein	10 percent owner	C/O RA MEDICAL SYSTEMS, INC., 2070 LAS PALMAS DRIVE, CARLSBAD CA 92011